This Article Full Text Full Text (PDF) All Versions of this Article: 38/9/2619    most recent STROKEAHA.107.489112v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, R. Articles by Fazekas, F. Search for Related Content PubMed PubMed Citation Articles by Schmidt, R. Articles by Fazekas, F. Related Collections Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2007;38:2619.)
© 2007 American Heart Association, Inc.

Topical Review

Progression of Leukoaraiosis and Cognition

Reinhold Schmidt, MD; Katja Petrovic, PhD; Stefan Ropele, PhD; Christian Enzinger, MD Franz Fazekas, MD

From the Department of Neurology (R.S., K.P., S.R., C.E., F.F.) and, the Division of Neuroradiology (R.S., C.E.), Department of Radiology, Medical University of Graz, Austria.

Correspondence to Reinhold Schmidt, MD, Professor of Neurology, Department of Neurology, Medical University of Graz, Auenbruggerplatz 22, 8036- Graz, Austria. E-mail reinhold.schmidt{at}meduni-graz.at

Section Editor: Marc Fisher MD

Abstract

Background and Purpose— Leukoaraiosis is used interchangeably with the term white matter lesions on MRI and seen to some degree in more than half of the routine scans in older persons. Clinicians often struggle to explain the implications of these findings to their patients. Recent data on the progression rate of ischemic white matter damage and its cognitive consequences may help in patient counseling and have implications on treatment trials in vascular cognitive impairment.

Summary of Review—Leukoaraiosis progresses over time. Its extent at baseline is an important predictor for the subsequent rate of lesion progression. Subjects with punctate abnormalities on MRI have a low tendency for progression, individuals with early confluent and confluent changes tend to progress rapidly. Differences in measurement methods and cohort composition make it difficult to compare progression rates reported by different studies. Nevertheless, in community-dwelling cohorts, white matter lesions volume increased by as much as one quarter per year in subjects with confluent abnormalities at baseline. Progression of leukoaraiosis relates to cognitive decline, but this association is complex and modulated by other morphological factors like brain atrophy.

Conclusions— Evidence for rapid progression of widespread leukoaraiosis and the associated cognitive decline in domains particularly affected by cerebral small vessel disease has set the stage for exploratory clinical trials in vascular cognitive impairment using white matter lesions progression as a surrogate marker.

Key Words: cognition • leukoaraiosis • MRI

This article has been cited by other articles:

				L. Pantoni Leukoaraiosis: From an Ancient Term to an Actual Marker of Poor Prognosis Stroke, May 1, 2008; 39(5): 1401 - 1403. [Full Text] [PDF]

				P. B. Gorelick and J. V. Bowler Advances in Vascular Cognitive Impairment 2007 Stroke, February 1, 2008; 39(2): 279 - 282. [Full Text] [PDF]